{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T21:55:03Z","timestamp":1715723703089},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,7]]},"DOI":"10.7759\/cureus.43073","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T14:38:42Z","timestamp":1691419122000},"source":"Crossref","is-referenced-by-count":1,"title":["A Comprehensive Systematic Review of the Latest Management Strategies for Hepatorenal Syndrome: A Complicated Syndrome to Tackle"],"prefix":"10.7759","author":[{"given":"Pooja","family":"Roy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naofel","family":"Minhaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prince","family":"Shah-Riar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sultana Y","family":"Simona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasniem","family":"Tasha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahira","family":"Binte Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhana Karim","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhana","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamima A","family":"Nila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janifa","family":"Akter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharmin","family":"Akter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shammo","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigar","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16084","article-title":"A review of hepatorenal syndrome","volume":"13","author":"Subedi A","year":"2021","unstructured":"Subedi A, Suresh Kumar VC, Sharma Subedi A, Sapkota B. A review of hepatorenal syndrome. Cureus. 2021, 13:e16084. 10.7759\/cureus.16084","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2478\/rjim-2021-0006","article-title":"Hepatorenal syndrome: pathophysiology and evidence-based management update","volume":"59","author":"Hasan I","year":"2021","unstructured":"Hasan I, Rashid T, Chirila RM, Ghali P, Wadei HM. Hepatorenal syndrome: pathophysiology and evidence-based management update. Rom J Intern Med. 2021, 59:227-61. 10.2478\/rjim-2021-0006","journal-title":"Rom J Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2020.00011","article-title":"Management of hepatorenal syndrome: a review","volume":"8","author":"Tariq R","year":"2020","unstructured":"Tariq R, Singal AK. Management of hepatorenal syndrome: a review. J Clin Transl Hepatol. 2020, 8:192-9. 10.14218\/JCTH.2020.00011","journal-title":"J Clin Transl Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-022-02618-x","article-title":"Establishment and evaluation of an early prediction model of hepatorenal syndrome in patients with decompensated hepatitis B cirrhosis","volume":"23","author":"Wang S","year":"2023","unstructured":"Wang S, Zhou Z, Xu C, et al.. Establishment and evaluation of an early prediction model of hepatorenal syndrome in patients with decompensated hepatitis B cirrhosis. BMC Gastroenterol. 2023, 23:1. 10.1186\/s12876-022-02618-x","journal-title":"BMC Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2020.07.008","article-title":"An integrated review of the hepatorenal syndrome","volume":"22","author":"Ojeda-Yuren AS","year":"2021","unstructured":"Ojeda-Yuren AS, Cerda-Reyes E, Herrero-Maceda MR, Castro-Narro G, Piano S. An integrated review of the hepatorenal syndrome. Ann Hepatol. 2021, 22:100236. 10.1016\/j.aohep.2020.07.008","journal-title":"Ann Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0010.8660","article-title":"Treatment of type-1 hepatorenal syndrome with pentoxifylline: a randomized placebo controlled clinical trial","volume":"17","author":"Stine JG","year":"2018","unstructured":"Stine JG, Wang J, Cornella SL, et al.. Treatment of type-1 hepatorenal syndrome with pentoxifylline: a randomized placebo controlled clinical trial. Ann Hepatol. 2018, 17:300-6. 10.5604\/01.3001.0010.8660","journal-title":"Ann Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-020-04762-6","article-title":"Hepatorenal syndrome in children: a review","volume":"36","author":"Liu PM","year":"2021","unstructured":"Liu PM, de Carvalho ST, Fradico PF, Cazumb\u00e1 ML, Campos RG, Sim\u00f5es e Silva AC. Hepatorenal syndrome in children: a review. Pediatr Nephrol. 2021, 36:2203-15. 10.1007\/s00467-020-04762-6","journal-title":"Pediatr Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S323778","article-title":"A review for the practicing clinician: hepatorenal syndrome, a form of acute kidney injury, in patients with cirrhosis","volume":"14","author":"Chaney A","year":"2021","unstructured":"Chaney A. A review for the practicing clinician: hepatorenal syndrome, a form of acute kidney injury, in patients with cirrhosis. Clin Exp Gastroenterol. 2021, 14:385-96. 10.2147\/CEG.S323778","journal-title":"Clin Exp Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4166\/kjg.2018.72.2.64","article-title":"Acute kidney injury and hepatorenal syndrome","volume":"72","author":"Kim MY","year":"2018","unstructured":"Kim MY, Seo YS. Acute kidney injury and hepatorenal syndrome. Korean J Gastroenterol. 2018, 72:64-73. 10.4166\/kjg.2018.72.2.64","journal-title":"Korean J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001462","article-title":"Management and outcomes of hepatorenal syndrome at an urban academic medical center: a retrospective study","volume":"31","author":"Bashir MH","year":"2019","unstructured":"Bashir MH, Iqbal S, Miller R, et al.. Management and outcomes of hepatorenal syndrome at an urban academic medical center: a retrospective study. Eur J Gastroenterol Hepatol. 2019, 31:1545-9. 10.1097\/MEG.0000000000001462","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14703","article-title":"Terlipressin has stood the test of time: clinical overview in 2020 and future perspectives","volume":"40","author":"Kulkarni AV","year":"2020","unstructured":"Kulkarni AV, Arab JP, Premkumar M, et al.. Terlipressin has stood the test of time: clinical overview in 2020 and future perspectives. Liver Int. 2020, 40:2888-905. 10.1111\/liv.14703","journal-title":"Liver Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/lt.26065","article-title":"Feasibility and effectiveness of norepinephrine outside the intensive care setting for treatment of hepatorenal syndrome","volume":"27","author":"Kwong A","year":"2021","unstructured":"Kwong A, Kim WR, Kwo PY, Wang U, Cheng X. Feasibility and effectiveness of norepinephrine outside the intensive care setting for treatment of hepatorenal syndrome. Liver Transpl. 2021, 27:1095-105. 10.1002\/lt.26065","journal-title":"Liver Transpl"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2021.09.008","article-title":"Transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome-chronic kidney disease: impact on renal function","volume":"54","author":"Ponzo P","year":"2022","unstructured":"Ponzo P, Campion D, Rizzo M, et al.. Transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome-chronic kidney disease: impact on renal function. Dig Liver Dis. 2022, 54:1101-8. 10.1016\/j.dld.2021.09.008","journal-title":"Dig Liver Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010431","article-title":"Terlipressin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis","volume":"97","author":"Wang H","year":"2018","unstructured":"Wang H, Liu A, Bo W, Feng X, Hu Y. Terlipressin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis. Medicine. 2018, 97:e0431. 10.1097\/MD.0000000000010431","journal-title":"Medicine"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2022.01.002","article-title":"Hepatorenal syndrome: definitions, diagnosis, and management","volume":"26","author":"Buccheri S","year":"2022","unstructured":"Buccheri S, Da BL. Hepatorenal syndrome: definitions, diagnosis, and management. Clin Liver Dis. 2022, 26:181-201. 10.1016\/j.cld.2022.01.002","journal-title":"Clin Liver Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajg.2022.01.005","article-title":"Update on hepatorenal syndrome: definition, pathogenesis, and management","volume":"23","author":"Habas E","year":"2022","unstructured":"Habas E, Ibrahim AR, Moursi MO, Shraim BA, Elgamal ME, Elzouki AN. Update on hepatorenal syndrome: definition, pathogenesis, and management. Arab J Gastroenterol. 2022, 23:125-33. 10.1016\/j.ajg.2022.01.005","journal-title":"Arab J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000730","article-title":"Advances in management of hepatorenal syndrome","volume":"30","author":"Khemichian S","year":"2021","unstructured":"Khemichian S, Francoz C, Nadim MK. Advances in management of hepatorenal syndrome. Curr Opin Nephrol Hypertens. 2021, 30:501-6. 10.1097\/MNH.0000000000000730","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/lt.26072","article-title":"The current management of hepatorenal syndrome-acute kidney injury in the United States and the potential of terlipressin","volume":"27","author":"Flamm SL","year":"2021","unstructured":"Flamm SL, Brown K, Wadei HM, et al.. The current management of hepatorenal syndrome-acute kidney injury in the United States and the potential of terlipressin. Liver Transpl. 2021, 27:1191-202. 10.1002\/lt.26072","journal-title":"Liver Transpl"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001950","article-title":"Safety and efficacy of outpatient continuous terlipressin infusion for the treatment of portal hypertensive complications in cirrhosis","volume":"34","author":"Gow PJ","year":"2022","unstructured":"Gow PJ, Sinclair M, Thwaites PA, Angus PW, Chapman B, Terbah R, Testro AG. Safety and efficacy of outpatient continuous terlipressin infusion for the treatment of portal hypertensive complications in cirrhosis. Eur J Gastroenterol Hepatol. 2022, 34:206-12. 10.1097\/MEG.0000000000001950","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-018-0876-3","article-title":"Noradrenaline versus terlipressin in the management of type 1 hepatorenal syndrome: a randomized controlled study","volume":"37","author":"Saif RU","year":"2018","unstructured":"Saif RU, Dar HA, Sofi SM, Andrabi MS, Javid G, Zargar SA. Noradrenaline versus terlipressin in the management of type 1 hepatorenal syndrome: a randomized controlled study. Indian J Gastroenterol. 2018, 37:424-9. 10.1007\/s12664-018-0876-3","journal-title":"Indian J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v13.i9.1058","article-title":"Liver kidney crosstalk: hepatorenal syndrome","volume":"13","author":"Nassar M","year":"2021","unstructured":"Nassar M, Nso N, Medina L, et al.. Liver kidney crosstalk: hepatorenal syndrome. World J Hepatol. 2021, 13:1058-68. 10.4254\/wjh.v13.i9.1058","journal-title":"World J Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i26.3984","article-title":"Acute kidney injury and hepatorenal syndrome in cirrhosis","volume":"27","author":"Gupta K","year":"2021","unstructured":"Gupta K, Bhurwal A, Law C, et al.. Acute kidney injury and hepatorenal syndrome in cirrhosis. World J Gastroenterol. 2021, 27:3984-4003. 10.3748\/wjg.v27.i26.3984","journal-title":"World J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13893","article-title":"Hepatorenal syndrome in the era of acute kidney injury","volume":"38","author":"Sol\u00e9 C","year":"2018","unstructured":"Sol\u00e9 C, Pose E, Sol\u00e0 E, Gin\u00e8s P. Hepatorenal syndrome in the era of acute kidney injury. Liver Int. 2018, 38:1891-901. 10.1111\/liv.13893","journal-title":"Liver Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/17562848221102679","article-title":"Management of hepatorenal syndrome in liver cirrhosis: a recent update","volume":"15","author":"Bera C","year":"2022","unstructured":"Bera C, Wong F. Management of hepatorenal syndrome in liver cirrhosis: a recent update. Ther Adv Gastroenterol. 2022, 15:17562848221102679. 10.1177\/17562848221102679","journal-title":"Ther Adv Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.05.041","article-title":"New developments in hepatorenal syndrome","volume":"16","author":"Mindikoglu AL","year":"2018","unstructured":"Mindikoglu AL, Pappas SC. New developments in hepatorenal syndrome. Clin Gastroenterol Hepatol. 2018, 16:162-77. 10.1016\/j.cgh.2017.05.041","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i28.3684","article-title":"Acute kidney injury spectrum in patients with chronic liver disease: where do we stand?","volume":"25","author":"Chancharoenthana W","year":"2019","unstructured":"Chancharoenthana W, Leelahavanichkul A. Acute kidney injury spectrum in patients with chronic liver disease: where do we stand?. World J Gastroenterol. 2019, 25:3684-703. 10.3748\/wjg.v25.i28.3684","journal-title":"World J Gastroenterol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.12703\/r\/10-48","article-title":"Recent advances in the understanding and management of hepatorenal syndrome","volume":"10","author":"Simbrunner B","year":"2021","unstructured":"Simbrunner B, Trauner M, Reiberger T, Mandorfer M. Recent advances in the understanding and management of hepatorenal syndrome. Fac Rev. 2021, 10:48. 10.12703\/r\/10-48","journal-title":"Fac Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.12451018","article-title":"Hepatorenal syndrome","volume":"14","author":"Francoz C","year":"2019","unstructured":"Francoz C, Durand F, Kahn JA, et al.. Hepatorenal syndrome. Clin J Am Soc Nephrol. 2019, 14:774-81. 10.2215\/CJN.12451018","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/lt.24609","article-title":"Management of renal failure in end-stage liver disease: a critical appraisal","volume":"22","author":"Cheng XS","year":"2016","unstructured":"Cheng XS, Tan JC, Kim WR. Management of renal failure in end-stage liver disease: a critical appraisal. Liver Transpl. 2016, 22:1710-9. 10.1002\/lt.24609","journal-title":"Liver Transpl"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13790","article-title":"Protecting the kidney in liver transplant candidates: practice-based recommendations from the American Society of Transplantation Liver and Intestine Community of Practice","volume":"16","author":"O'Leary JG","year":"2016","unstructured":"O'Leary JG, Levitsky J, Wong F, Nadim MK, Charlton M, Kim WR. Protecting the kidney in liver transplant candidates: practice-based recommendations from the American Society of Transplantation Liver and Intestine Community of Practice. Am J Transplant. 2016, 16:2516. 10.1111\/ajt.13790","journal-title":"Am J Transplant"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Laleman W","year":"2018","unstructured":"Laleman W, European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018, 69:406. 10.1016\/j.jhep.2018.03.024","journal-title":"J Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-019-09980-1","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update","volume":"13","author":"Sarin SK","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, et al.. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019, 13:826-8. 10.1007\/s12072-019-09980-1","journal-title":"Hepatol Int"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins SW","year":"2021","unstructured":"Biggins SW, Angel P, Garcia-Tsao G, et al.. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021, 74:1014-48. 10.1002\/hep.31884","journal-title":"Hepatology"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001595","article-title":"Acute-on-chronic liver failure clinical guidelines","volume":"117","author":"Bajaj JS","year":"2022","unstructured":"Bajaj JS, O'Leary JG, Lai JC, Wong F, Long MD, Wong RJ, Kamath PS. Acute-on-chronic liver failure clinical guidelines. Am J Gastroenterol. 2022, 117:225-52. 10.14309\/ajg.0000000000001595","journal-title":"Am J Gastroenterol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.03.019","article-title":"Update in the treatment of the complications of cirrhosis","volume":"21","author":"Abraldes JG","year":"2023","unstructured":"Abraldes JG, Caraceni P, Ghabril M, Garcia-Tsao G. Update in the treatment of the complications of cirrhosis. Clin Gastroenterol Hepatol. 2023, 21:2100-9. 10.1016\/j.cgh.2023.03.019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong F","year":"2021","unstructured":"Wong F, Pappas SC, Curry MP, et al.. Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome. N Engl J Med. 2021, 384:818-28. 10.1056\/NEJMoa2008290","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.09.012","article-title":"Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites","volume":"46","author":"Kalambokis G","year":"2007","unstructured":"Kalambokis G, Fotopoulos A, Economou M, Pappas K, Tsianos EV. Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites. J Hepatol. 2007, 46:213-21. 10.1016\/j.jhep.2006.09.012","journal-title":"J Hepatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9312-0","article-title":"Octreotide\/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome","volume":"52","author":"Esrailian E","year":"2007","unstructured":"Esrailian E, Pantangco ER, Kyulo NL, Hu KQ, Runyon BA. Octreotide\/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig Dis Sci. 2007, 52:742-8. 10.1007\/s10620-006-9312-0","journal-title":"Dig Dis Sci"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22008","article-title":"Pretransplant predictors of recovery of renal function after liver transplantation","volume":"16","author":"Northup PG","year":"2010","unstructured":"Northup PG, Argo CK, Bakhru MR, Schmitt TM, Berg CL, Rosner MH. Pretransplant predictors of recovery of renal function after liver transplantation. Liver Transpl. 2010, 16:440-6. 10.1002\/lt.22008","journal-title":"Liver Transpl"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27015","article-title":"Hepatorenal syndrome type 1 and bacterial infection: a catastrophic association in patients with cirrhosis","volume":"59","author":"Salerno F","year":"2014","unstructured":"Salerno F, Monti V. Hepatorenal syndrome type 1 and bacterial infection: a catastrophic association in patients with cirrhosis. Hepatology. 2014, 59:1239-41. 10.1002\/hep.27015","journal-title":"Hepatology"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/cld.819","article-title":"Prophylactic antibiotics in cirrhosis: are they promoting or preventing infections?","volume":"14","author":"Garcia-Tsao G","year":"2019","unstructured":"Garcia-Tsao G. Prophylactic antibiotics in cirrhosis: are they promoting or preventing infections?. Clin Liver Dis (Hoboken). 2019, 14:98-102. 10.1002\/cld.819","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fern\u00e1ndez J","year":"2007","unstructured":"Fern\u00e1ndez J, Navasa M, Planas R, et al.. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology. 2007, 133:818-24. 10.1053\/j.gastro.2007.06.065","journal-title":"Gastroenterology"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.2174\/1389450119666180924145156","article-title":"Safety and efficacy of rifaximin in prophylaxis of spontaneous bacterial peritonitis: a systematic review and meta-analysis","volume":"20","author":"Menshawy A","year":"2019","unstructured":"Menshawy A, Mattar O, Barssoum K, et al.. Safety and efficacy of rifaximin in prophylaxis of spontaneous bacterial peritonitis: a systematic review and meta-analysis. Curr Drug Targets. 2019, 20:380-7. 10.2174\/1389450119666180924145156","journal-title":"Curr Drug Targets"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo A","year":"1994","unstructured":"Follo A, Llovet JM, Navasa M, et al.. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology. 1994, 20:1495-501. 10.1002\/hep.1840200619","journal-title":"Hepatology"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis","volume":"38","author":"Ruiz-del-Arbol L","year":"2003","unstructured":"Ruiz-del-Arbol L, Urman J, Fern\u00e1ndez J, et al.. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 2003, 38:1210-8. 10.1053\/jhep.2003.50447","journal-title":"Hepatology"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.09.013","article-title":"Pathogenesis of hepatorenal syndrome: implications for therapy","volume":"67","author":"Durand F","year":"2016","unstructured":"Durand F, Graupera I, Gin\u00e8s P, Olson JC, Nadim MK. Pathogenesis of hepatorenal syndrome: implications for therapy. Am J Kidney Dis. 2016, 67:318-28. 10.1053\/j.ajkd.2015.09.013","journal-title":"Am J Kidney Dis"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005595","article-title":"The comparative effectiveness of vasoactive treatments for hepatorenal syndrome: a systematic review and network meta-analysis","volume":"50","author":"Pitre T","year":"2022","unstructured":"Pitre T, Kiflen M, Helmeczi W, et al.. The comparative effectiveness of vasoactive treatments for hepatorenal syndrome: a systematic review and network meta-analysis. Crit Care Med. 2022, 50:1419-29. 10.1097\/CCM.0000000000005595","journal-title":"Crit Care Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S264231","article-title":"Albumin administration is efficacious in the management of patients with cirrhosis: a systematic review of the literature","volume":"12","author":"Zaccherini G","year":"2020","unstructured":"Zaccherini G, Tufoni M, Bernardi M. Albumin administration is efficacious in the management of patients with cirrhosis: a systematic review of the literature. Hepat Med. 2020, 12:153-72. 10.2147\/HMER.S264231","journal-title":"Hepat Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12359","article-title":"Outcome of patients treated with molecular adsorbent recirculating system albumin dialysis: a national multicenter study","volume":"4","author":"Camus C","year":"2020","unstructured":"Camus C, Locher C, Saliba F, et al.. Outcome of patients treated with molecular adsorbent recirculating system albumin dialysis: a national multicenter study. JGH Open. 2020, 4:757-63. 10.1002\/jgh3.12359","journal-title":"JGH Open"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.923805","article-title":"Application of the molecular adsorbent recirculating system in type 1 hepatorenal syndrome in the course of alcohol-related acute on chronic liver failure","volume":"26","author":"Kade G","year":"2020","unstructured":"Kade G, Lubas A, Spaleniak S, et al.. Application of the molecular adsorbent recirculating system in type 1 hepatorenal syndrome in the course of alcohol-related acute on chronic liver failure. Med Sci Monit. 2020, 26:e923805. 10.12659\/MSM.923805","journal-title":"Med Sci Monit"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/157950-a-comprehensive-systematic-review-of-the-latest-management-strategies-for-hepatorenal-syndrome-a-complicated-syndrome-to-tackle","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:41Z","timestamp":1707509081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/157950-a-comprehensive-systematic-review-of-the-latest-management-strategies-for-hepatorenal-syndrome-a-complicated-syndrome-to-tackle"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.43073","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,7]]}}}